Centene (CNC) | Stock Overview & Key Data
Centene Performance Comparison
Stock Range
Today's Range
Low: $27.76
High: $28.68
on August 15, 2025
52 Week Range
Low: $25.08
High: $80.59
on August 7, 2025
on September 3, 2024
All-Time High: $98.53 on August 15, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$12.9B
EPS
4.12
P/E Ratio (TTM)
6.35
Forward P/E
3.72
P/B Ratio
0.47
PEG Ratio
3.72
Div. Yield
N/A
ROE
7.44%
Beta
0.400
Debt to Equity
63.91
Financial Highlights
Profitability
Gross Margin
6.05%
Operating Margin
-0.07%
Profit Margin
1.29%
Returns and Earnings
Return on Assets (TTM)
2.50%
Return on Equity (TTM)
7.44%
EBITDA
$4.4B
Net Income (TTM)
$2.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$321.75
Quarterly Revenue Growth (YoY)
17.60%
Quarterly Earnings Growth (YoY)
22.36%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Centene CNC | 12.85B Large-cap | 11.33% | -5.03% | -52.56% | -49.06% | -52.92% | -63.53% | -70.60% | -54.39% |
| UnitedHealth UNH | 244.53B Mega-cap | 21.22% | 4.26% | 10.86% | -39.26% | -39.72% | -47.37% | -44.56% | -3.22% |
| CVS Health CVS | 83.09B Large-cap | 4.67% | 7.29% | 13.44% | 4.62% | 55.13% | 17.57% | -34.07% | 7.29% |
| Cigna CI | 74.87B Large-cap | 7.99% | -1.84% | -3.89% | 0.72% | 8.15% | -13.28% | 1.32% | 66.49% |
| Elevance Health ELV | 65.86B Large-cap | 5.30% | -7.92% | -20.62% | -19.06% | -15.38% | -43.06% | -38.52% | 8.76% |
| Humana HUM | 33.92B Large-cap | 7.39% | 29.06% | 25.90% | 11.33% | 13.35% | -18.26% | -42.71% | -31.61% |
Ownership & Short Interest
Insider Ownership
0.46%
Institutional Ownership
101.59%
Shares Short
28M
Short Ratio
1.10
Short % of Shares Outstanding
6.48%
Average 10-Day Volume
16M
Average 90-Day Volume
23M
Centene Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Centene would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CNC's 52-week high and low?
- In the last 52 weeks, Centene reached a high of $80.59 (on September 3, 2024) and a low of $25.08 (on August 7, 2025).
- What is the market cap and P/E ratio for CNC?
- Curious about Centene's size and valuation? Its market capitalization stands at 12.85B. When it comes to valuation, the P/E ratio (trailing twelve months) is 6.35, and the forward P/E (looking ahead) is 3.72.
- Does CNC pay dividends? If so, what's the yield?
- As for dividends, Centene isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Centene's main competitors or similar companies to consider before investing?
When looking at Centene, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH244.53B Healthcare Healthcare Plans -47.37% -44.56% CVS Health
CVS83.09B Healthcare Healthcare Plans 17.57% -34.07% Cigna
CI74.87B Healthcare Healthcare Plans -13.28% 1.32% Elevance Health
ELV65.86B Healthcare Healthcare Plans -43.06% -38.52% Humana
HUM33.92B Healthcare Healthcare Plans -18.26% -42.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Centene Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Centene's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.44%, the Debt to Equity ratio from the most recent quarter is 63.91, and its Gross Profit Margin stands at 6.05%.
- What is the recent revenue and earnings growth for CNC?
- Looking at Centene's growth, its revenue over the trailing twelve months (TTM) was $160B. Compared to the same quarter last year (YoY), quarterly revenue grew by 17.60%, and quarterly earnings saw a YoY growth of 22.36%.
- How much of CNC stock is held by insiders and institutions?
- Wondering who owns Centene stock? Company insiders (like executives and directors) hold about 0.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.59%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.